Targeted norfloxacin is active in vivo against persistent Mycobacterium bovis BCG.

Journal of controlled release : official journal of the Controlled Release Society

Volumn 101, Issue 1-3, 2005, Pages 343-345

  Domurado, D ^a   Balazuc, A M ^a   Lagranderie, M ^a   Pescher, P ^a   Chavarot, P ^a   Roseeuw, E ^a   Coessens, V ^a   Stern, S ^a   Schacht, E ^a   Marchal, G ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NORFLOXACIN; PRODRUG;

ANIMAL; ARTICLE; C57BL MOUSE; DRUG EFFECT; MOUSE; MYCOBACTERIUM BOVIS; TUBERCULOSIS;

ANIMALS; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; NORFLOXACIN; PRODRUGS; TUBERCULOSIS;

EID: 17144418529     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)